• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放线菌酮和衣霉素对大鼠FRTL-5细胞溶酶体胱氨酸转运的影响。

Effects of cycloheximide and tunicamycin on lysosomal cystine transport in rat FRTL-5 cells.

作者信息

Gahl W A, Bernardini I, Tietze F, Kohn L D

机构信息

Section on Human Biochemical Genetics, National Institute of Child Health and Human Development, Bethesda, Maryland 20892.

出版信息

Biochem Med Metab Biol. 1993 Apr;49(2):243-54. doi: 10.1006/bmmb.1993.1026.

DOI:10.1006/bmmb.1993.1026
PMID:8484963
Abstract

Rat thyroid FRTL-5 cells were employed to study the synthesis and degradation of a functional integral lysosomal membrane protein, the lysosomal cystine transporter. This carrier exhibited countertransport and closely resembled the cystine transport system of human leucocytes, fibroblasts, and lymphoblasts shown to be defective in the lysosomal storage disease, nephropathic cystinosis. Using cycloheximide to prevent new protein synthesis, the half-life of the FRTL-5 cell lysosomal cystine carrier was determined to approximate 21 h. Carrier function was not influenced by the N-glycosylation inhibitor tunicamycin, nor by the oligosaccharide processing inhibitors castanospermine and deoxymannojirimycin. The data suggest that the lysosomal cystine carrier is a protein without strict functional requirements for N-linked oligosaccharides, and that rat FRTL-5 cells can be employed in future investigations into the structure and function of other integral lysosomal membrane proteins as well.

摘要

采用大鼠甲状腺FRTL-5细胞来研究一种功能性完整溶酶体膜蛋白——溶酶体胱氨酸转运体的合成与降解。这种载体表现出反向转运,并且与人类白细胞、成纤维细胞和淋巴母细胞的胱氨酸转运系统极为相似,而这些细胞的胱氨酸转运系统在溶酶体贮积病——肾病性胱氨酸病中被证明存在缺陷。使用环己酰亚胺来阻止新蛋白质的合成,测定出FRTL-5细胞溶酶体胱氨酸载体的半衰期约为21小时。载体功能不受N-糖基化抑制剂衣霉素的影响,也不受寡糖加工抑制剂蓖麻毒蛋白和脱氧甘露基野尻霉素的影响。这些数据表明,溶酶体胱氨酸载体是一种对N-连接寡糖没有严格功能要求的蛋白质,并且大鼠FRTL-5细胞也可用于未来对其他完整溶酶体膜蛋白的结构和功能的研究。

相似文献

1
Effects of cycloheximide and tunicamycin on lysosomal cystine transport in rat FRTL-5 cells.放线菌酮和衣霉素对大鼠FRTL-5细胞溶酶体胱氨酸转运的影响。
Biochem Med Metab Biol. 1993 Apr;49(2):243-54. doi: 10.1006/bmmb.1993.1026.
2
Thyrotropin stimulation of lysosomal tyrosine transport in rat FRTL-5 thyroid cells.促甲状腺激素对大鼠FRTL-5甲状腺细胞溶酶体酪氨酸转运的刺激作用。
J Biol Chem. 1988 Jul 5;263(19):9320-5.
3
Characterization of lysosomal monoiodotyrosine transport in rat thyroid cells. Evidence for transport by system h.大鼠甲状腺细胞中溶酶体单碘酪氨酸转运的特征。系统h介导转运的证据。
J Biol Chem. 1990 Jul 5;265(19):10950-4.
4
Inhibitors of protein synthesis also inhibit lysosomal proteolysis. Studies using cystinotic fibroblasts.
J Clin Invest. 1985 Feb;75(2):370-6. doi: 10.1172/JCI111709.
5
Characterization of the lysosomal cystine transport system in mouse L-929 fibroblasts.小鼠L-929成纤维细胞中溶酶体胱氨酸转运系统的特性研究
J Biol Chem. 1990 Jun 15;265(17):9888-95.
6
Lysosomal cystine transport in cystinosis variants and their parents.胱氨酸贮积症变体及其父母中的溶酶体胱氨酸转运
Pediatr Res. 1987 Feb;21(2):193-6. doi: 10.1203/00006450-198702000-00016.
7
Characterization of the rat thyroid iodide transporter using anti-peptide antibodies. Relationship between its expression and activity.利用抗肽抗体对大鼠甲状腺碘转运体进行表征。其表达与活性之间的关系。
J Biol Chem. 1997 Jul 18;272(29):18245-9. doi: 10.1074/jbc.272.29.18245.
8
Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis.胱氨酸病患者分离出的白细胞溶酶体中胱氨酸转运存在缺陷。
Science. 1982 Sep 24;217(4566):1263-5. doi: 10.1126/science.7112129.
9
Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter.胱氨酸转运蛋白,即导致胱氨酸病的缺陷蛋白,是一种由氢离子驱动的溶酶体胱氨酸转运体。
EMBO J. 2001 Nov 1;20(21):5940-9. doi: 10.1093/emboj/20.21.5940.
10
Lysosomal cystine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cells.溶酶体胱氨酸蓄积增强培养的人成纤维细胞和肾小管上皮细胞中的细胞凋亡。
J Am Soc Nephrol. 2002 Dec;13(12):2878-87. doi: 10.1097/01.asn.0000036867.49866.59.